Goldman Sachs AM Closes First Fund in Life Sciences Investing Strategy
-
Inaugural strategy is one of the largest ever first-time private life sciences growth funds
-
Fundraise closed above its original target, reflecting strong interest from institutional, strategic and high net worth investors
Goldman Sachs Asset Management announced the final close of West Street Life Sciences I (“Life Sciences I” or the “Fund”), representing the first fund in the firm’s Life Sciences Investing strategy.
Life Sciences I closed above its fundraising target, with $650 million in equity commitments from a global, diverse group of institutional, strategic and high net worth investors and meaningful commitment…
